Scotch Plains, NJ (PRWEB) December 21, 2022 Raja M. Flores, MD of Mount Sinai Health System’s Department of Thoracic Surgery has been reviewed and approved
Axicabtagene ciloleucel (axi-cel), a form of CAR-T therapy appears to be safe and has encouraging signs of efficacy in treating both lymphoma of the brain and spinal cord injury.
Menarini Silicon Biosystems Announces Study Results Presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCH CMMC assay, a Non-Invasive Liquid Biopsy for the